Diligence memo · auto-generated · as of July 2, 2026

Assured Pharmacy, Inc.

Assured Pharmacy, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Assured Pharmacy, Inc. operates in Other Health Care, based in FRISCO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Assured Pharmacy, Inc. has raised $3.2M in disclosed capital across 6 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $740K on 2011-11-29.

Most recent recorded round closed around 2013-02-05.

Valuation (modeled)modeled

Provath models Assured Pharmacy, Inc. at approximately $18M (range $376K–$210M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.85× the median modeled value of Pre-Seed Other Health Care companies in 2013–2015 (343 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 13.4 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.2× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 56% of Other Health Care peers (5377 compared).

Modeled value ranks above 47% of those peers.

Closest niche peers: Optimized Care Network, LLC, Ludi, Inc., Pure Life Renal LLC, Surgery Center of Kenai, LLC, SpineDynx, LLC.

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.